Improve Return On Test Investment By Reducing Capital & Operating Expenses

Test Asset Optimization Services Saves CapEx and Avoids Downtime with Utilization and Health Monitoring


Keysight has announced Test Asset Optimization Services, an integrated solution that measures in real-time, asset true utilization and health, to dramatically improve a company’s return on test investment and decrease capital and operating expenses for equipment used in R&D and manufacturing. Keysight says that its solution eliminates the need for companies to assign personnel to manually record when instruments are in use and making measurements.

This integrated solution will help customers unlock hidden costs by delivering real-time test-asset utilization, equipment health status, and overall recommendations on areas for savings.

“With test asset utilization as low as 10% for many assets at a company and no proven way to measure true asset utilization and health, many assets sit idle or underutilized at a large opportunity cost”, Keysight explained.

Providing actionable transparency on multi-brand test assets enables companies to make informed decisions on current and future procurement.

An important part of the new Test Asset Optimization Services is PathWave Asset Advisor software, which is available cloud-hosted or on-premises. This software tracks and controls test assets, monitors utilization and health of selected assets, and allows loan pool capabilities for targeted assets.

This software is available in the Amazon Web Service (AWS) cloud, offering customers fast, and up-to-date functionality as well as reliable and secure web access to manage their assets. As a cloud-hosted solution, it eliminates the time and costs associated with IT network administration and data storage overhead.

The on-premise solution of PathWave Asset Advisor software resides on a server and behind the companies’ firewall. It operates in a standalone mode, with all the essential features for importing and exporting information.

More information:


Please enter your comment!
Please enter your name here